PHARMNEWS
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
ITC final initial determination Ruled in favor of Hugel (no violation of Section 337) 2024-06-11 11:33
Hugel Appointed Suk-yong Cha as Executive Chairman and Chairman of the Board Accelerating Transformation into a Global Top-tier Company 2023-03-31 20:00
Hugel Nominates Suk-yong Cha as Non-Executive Director 2023-03-09 23:00
Hugel Achieved Record-High Revenue and Operating Profit 2023-02-09 22:00
Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia 2022-11-24 22:00
Hugel resubmits BLA for its botulinum toxin, Botulax to the U.S. FDA 2022-10-08 11:00
1